ARCHIVES

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

NCI advisory Group, Other Cancer Meetings

March 29, 1985

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

NCI CTEP-Approved Trials For the Month of February

February 28, 2014

Wistar’s Koprowski; Rivera Is Director

April 12, 1991

AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows

August 28, 2009

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

February 11, 2011